B.C. Reg. 100/2025: Amendments to the Drug Schedules Regulation
Made under the Pharmacy Operations and Drug Scheduling Act
How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →
Get alerted when the next rule lands
New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
The rule, in full
173 words as published, July 15, 2025. View the original →
B.C. Reg. 100/2025, deposited July 3, 2025, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 22]. Resolution of the Board of the College of Pharmacists of British Columbia, dated April 24, 2025. The Board of the College of Pharmacists of British Columbia orders that the Drug Schedules Regulation, B.C. Reg. 9/98, is amended as set out in the attached Appendix. — S. SOLVEN, Chair, Board of the College of Pharmacists of British Columbia.
Appendix
1 The Drug Schedules Regulation, B.C. Reg. 9/98, is amended in the Schedules (a) by striking out the following: 3 Desloratadine and its salts and preparations (in products marketed for paediatric use – under 12 years of age) , and (b) by adding the following: 1 Desloratadine and its salts and preparations in products labelled for use in children under the age of 2 years 3 Desloratadine and its salts and preparations in products labelled for use in children aged 2 to 11 years, in package sizes containing greater than 35 mg of desloratadine 2 Nirsevimab .
Documents
- The text in The British Columbia Gazette · July 15, 2025